LEMAITRE VASCULAR, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
LEMAITRE VASCULAR, INC. (LMAT) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $5.34 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-08-05
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $5.34M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $5.25M.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $5.57M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $5.16M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-06-30 | $5.34M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $5.25M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $5.57M 10-K · filed 2026-02-26 |
| 2025-09-30 | $5.16M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $5.16M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $5.12M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $5.57M 10-K · filed 2025-02-28 |
| 2024-09-30 | $5.60M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $5.60M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $5.60M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $5.90M 10-K · filed 2024-02-29 |
| 2023-09-30 | $5.90M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $5.77M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $5.77M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $5.95M 10-K · filed 2023-03-01 |
| 2022-09-30 | $5.95M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $5.95M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $5.88M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $6.02M 10-K · filed 2022-02-28 |
| 2021-09-30 | $5.97M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $5.97M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $5.97M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $6.18M 10-K · filed 2021-03-12 |
| 2020-09-30 | $6.18M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $6.26M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $2.39M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $3.22M 10-K · filed 2020-03-12 |
| 2018-12-31 | $2.09M 10-K · filed 2019-03-11 |
| 2017-12-31 | $1.59M 10-K · filed 2018-03-09 |
| 2017-06-30 | $1.58M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $1.57M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $1.74M 10-K · filed 2017-03-09 |
| 2016-09-30 | $1.30M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $1.29M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $1.30M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $1.47M 10-K · filed 2016-03-10 |
| 2015-09-30 | $1.46M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $1.41M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $1.27M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $1.44M 10-K · filed 2015-03-18 |
| 2014-09-30 | $434.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $992.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $1.01M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $1.41M 10-K · filed 2014-03-21 |
| 2013-09-30 | $1.22M 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |